Results 191 to 200 of about 84,774 (336)

Artificial Intelligence in Optometry: Current and Future Perspectives

open access: yesClinical Optometry
Anantha Krishnan,1,* Ananya Dutta,2,* Alok Srivastava,3,4 Nagaraju Konda,1 Ruby Kala Prakasam5 1School of Medical Sciences, Science Complex, University of Hyderabad, Hyderabad, Telangana, India; 2Standard Chartered – LVPEI Academy for Eye Care ...
Krishnan A   +4 more
doaj  

Real‐world outcomes of aflibercept 8 mg in patients previously treated for neovascular age‐related macular degeneration

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and ...
Imadeddin Abu Ishkheidem   +5 more
wiley   +1 more source

Customizing AI‐based screening with real‐world data: Practical insights from diabetic retinopathy

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Diabetic retinopathy (DR) is a leading cause of vision loss in middle‐aged adults globally. Although artificial intelligence (AI)‐based screening tools like IDx‐DR (classification) and Thirona RetCAD (regression) have shown high sensitivity in controlled settings, real‐world screening faces challenges due to missing or low‐quality ...
Broder Poschkamp   +17 more
wiley   +1 more source

The Effect of Tinted Filters on the Visual Function of Patients with Retinitis Pigmentosa. [PDF]

open access: yesJ Ophthalmic Vis Res
Riazifar A   +7 more
europepmc   +1 more source

Fluid/function correlation using AI‐based quantification versus central subfield thickness in treatment‐naïve and pre‐treated patients with neovascular AMD in a real‐world setting

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To investigate the association between best‐corrected visual acuity (BCVA) and quantitative macular fluid volumes, compared to central subfield thickness (CST) in treatment‐naïve and previously treated patients with active neovascular age‐related macular degeneration (nAMD).
Anna Eidenberger   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy